Some multinational companies urged to open direct transaction

Two multinational companies are still hesitating to make an direct dealing with Dongwon Group Pharma, drawing strong criticism.

So far, these companies have shown lukewarm attitude over direct transaction.

According to sources, multination drug makers are said to lay out an internal plan to cope with mounting discontent over Zuellig’s tight margin policy.

Zuellig Pharma Korea has been...